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Abstract
A 30-year-old female with no signiﬁcant past medical history was referred
to our facility with sudden onset of shortness of breath. She had a low clini-
cal probability for pulmonary thromboembolism and a computed tomogra-
phy angiogram showed enlarged pulmonary arteries but no in situ thrombi.
She developed recurrent episodes of hypotension and hypoxia, and was
transferred to the intensive care unit where she died despite active resuscita-
tion. An autopsy revealed extensive lymphatic and pulmonary vascular
tumour emboli as the immediate cause of death. Pulmonary tumour embo-
lism is a very rare cause of death, but can occur in patients who have an
occult neoplasm.
Introduction
Pulmonary tumour embolism is a rare complication of
malignant disease and very occasionally presents as the ini-
tial and the sole manifestation of a primary malignant
disease.
Case Report
A 30-year-old female working as a courier and previously
well was referred to our facility with acute onset of severe
dyspnoea and central chest pain. She presented with a 4-
day history of dry cough and malaise, which had not
responded to prescribed antibiotics. There were no known
risks for pulmonary thromboembolism; history of preced-
ing loss of consciousness, trauma, weight loss, or fever; or
signiﬁcant past personal and family medical histories.
The ﬁndings on examination included a tachycardia
(120 beats/min), tachypnoea (32 breaths/min), hypoxia on
room air, normal blood pressure, and apyrexia. The chest
and cardiac exam ﬁndings were unremarkable, apart from
an accentuated second heart sound. The arterial blood
gas analysis while using an oxygen face mask (providing
40% oxygen) showed a mild respiratory alkalosis (pH,
7.51; partial pressure of carbon dioxide (PaCO2), 2.9 kPa;
and bicarbonate of 21.9 mmol/L) with a partial pressure
of oxygen (PaO2) of 18.8 kPa. Her electrocardiogram
showed a sinus tachycardia and features of right ventricu-
lar strain.
The rapid HIV antibody test was negative and the full
blood count, liver function tests, urea, creatinine, electro-
lytes, and International Normalised Ratio were normal.
The d-dimer was 0.34 mg/L (normal < 0.25 mg/L), ﬁbrin-
ogen was 1.2 mg/L (range: 2.0–4.0 mg/dL), and the C-
reactive protein was mildly elevated. An echocardiogram
showed severely dilated right heart chambers with elevated
right ventricular systolic pressures of 115 mmHg (range:
15–25 mmHg) and moderately impaired right ventricular
systolic function. There was paradoxical interventricular
septal bowing which was consistent with the right ventric-
ular overload and/or elevated right ventricular end-
diastolic pressure. The pulmonary artery was severely
dilated. The left heart was normal. Doppler ultrasound of
the lower limbs and abdomen did not show evidence of
thrombi; however, lymph nodes were noted in the porta
hepatis and para-aortic region.
The chest radiograph showed features of pulmonary
hypertension, namely, an enlarged right atrium, prominent
pulmonary outﬂow tract, enlarged pulmonary arteries, and
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pruning of peripheral pulmonary vessels with widening of
the mediastinum. The computed tomography
(CT) pulmonary angiogram conﬁrmed features of pulmo-
nary hypertension, while also revealing extensive mediasti-
nal adenopathy. Signiﬁcantly, the CT scan did not show
evidence of intraluminal pulmonary thrombi or features of
parenchymal lung disease (Fig. 1).
During the next 24 h, she developed cardiovascular
instability characterized by recurrent discrete episodes of
hypotension and hypoxia without arrhythmia, necessitat-
ing intermittent non-invasive positive pressure ventilation
and ﬂuid resuscitation with good inter-episode clinical
response. After the second such episode, she was thrombo-
lysed for suspected new massive pulmonary thromboem-
bolism and admitted to the intensive care unit. On the
65th hour from hospital admission and after a period of
clinical stability, she suffered a recurrent episode of hypo-
tension and hypoxia, and demised despite prolonged
resuscitation.
A post-mortem examination macroscopically showed
generalized lymphadenopathy and prominent small pul-
monary vessels. Microscopic examination of the enlarged
mediastinal lymph nodes showed a poorly differentiated
adenocarcinoma, which was also found in the peri-
pancreatic and peri-adrenal soft tissue and invading the
diaphragm. Examination of the lungs demonstrated multi-
ple organized tumour emboli occluding the pulmonary
vessels (Fig. 2).
Immunohistochemistry performed was positive for
CK20 and negative for CK7, which is typical for colorectal
adenocarcinomas. Macroscopic examination of the gastro-
intestinal system, however, failed to localize a macroscopic
lesion in the gastrointestinal tract. In addition, CDX-2
(usually positive in colorectal adenocarcinomas) tested
negative in this patient. The post-mortem was unable to
identify conclusively a primary location for this dissemi-
nated malignancy.
Figure 1. An axial contrasted computed tomography scan of the chest
showing enlarged main pulmonary trunk suggesting pulmonary hyper-
tension and extensive mediastinal lymphadenopathy.
Figure 2. Microscopic slides of sec-
tions of the lungs showing intravas-
cular collections of ﬁbrin and
markedly anaplastic tumour cells con-
sistent with poorly differentiated ade-
nocarcinoma. (A) A slide showing
tumour cells with associated throm-
bus in the pulmonary vessels
(arrows). Haematoxylin and eosin
stain. Original magniﬁcation 100×.
(B) A slide showing recanalization of
a thrombosed pulmonary blood ves-
sel. Note the individual tumour cells
(arrows). Haematoxylin and eosin
stain. Original magniﬁcation 200×.
(C) A slide illustrating intracytoplas-
mic mucin vacuoles in tumour cells
(arrows). Periodic acid-Schiff stain
treated with diastase. Original magni-
ﬁcation 400×. (D) A slide illustrating
positive staining (brown stain) of
tumour cells with an immunohisto-
chemical stain (cytokeratin cocktail)
for AE1/AE3 in keeping with a carci-
noma rather than a lymphoma or
melanoma. Original magniﬁca-
tion 100×.
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Discussion
Pulmonary tumour embolism refers to the identiﬁcation of
tumour within pulmonary blood vessels on pathological
lung samples. Invasion of the surrounding interstitium is
not typically seen, a feature that distinguishes it from pul-
monary metastases. It remains a rare and poorly described
complication of malignant disease, and its underlying
pathophysiology is not completely understood [1].
The risk of tumour emboli appears to be greatest with
renal cell and hepatocellular carcinoma as well as mucin-
secreting adenocarcinomas of the breast, lung, stomach,
and colon [2]. It usually, but not exclusively, occurs in
patients with an established diagnosis of malignant disease.
Antemortem diagnosis is challenging in clinical practice
and most information on tumour emboli have been
obtained from autopsy series or case reports [3]. Clinical
features are non-speciﬁc. Findings on special investigations
are also non-speciﬁc. Patients may demonstrate electrocar-
diographic signs of right-sided heart strain and right ven-
tricle hypertrophy. Arterial blood gases may reveal hypoxia
with an associated respiratory alkalosis due to hyperventi-
lation. Most imaging studies are insensitive for making a
diagnosis, particularly in the early phase. Chest radio-
graphs and CT are frequently normal, and pulmonary
arteriography is usually non-diagnostic. Ventilation–
perfusion lung scans may be normal or may demonstrate
multiple, small, peripheral, subsegmental perfusion defects
with normal ventilation. The optimal diagnostic approach
is not known. In suspected cases, histological diagnosis has
been pursued with a transbronchial lung biopsy, surgical
lung biopsy, or aspiration of pulmonary artery blood using
a right heart catheter [4].
Treatment is directed at the underlying malignancy and
supportive care. Pulmonary tumour emboli is typically an
end-stage manifestation of malignancy, and the prognosis
with or without therapy is generally poor after onset of
symptoms [5].
The patient was a young, previously healthy female with
no suggestive medical or family history. She presented with
rapid onset fatal cor pulmonale due to pulmonary tumour
embolism from an occult carcinoma of an unknown ori-
gin, which is extremely rare. Most cases of pulmonary
tumour embolism occur in patients with established
malignancies.
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